ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Capsule-based Inhalers Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-21R7413
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Capsule based Inhalers Market Insights Forecast to 2028
BUY CHAPTERS

Global Capsule-based Inhalers Market Insights, Forecast to 2030

Code: QYRE-Auto-21R7413
Report
December 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment

Capsule-based Inhalers Market

Capsule-based inhalers belong to the category of dry powder inhalers and work according to a simple two-step procedure. Capsules are punctured or opened by pressing the device buttons. Then, after inspiration, powder is absorbed into the lung pathway.
The global Capsule-based Inhalers market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Capsule-based Inhalers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Capsule-based Inhalers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Capsule-based Inhalers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Capsule-based Inhalers include Hovione, Iconovo AB, Inbrija, Utibron Neohaler (Novartis AG) and Zibo Laixu Medical Equipment, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Capsule-based Inhalers, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Capsule-based Inhalers, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Capsule-based Inhalers, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Capsule-based Inhalers sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Capsule-based Inhalers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Capsule-based Inhalers sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Capsule-based Inhalers Market Report

Report Metric Details
Report Name Capsule-based Inhalers Market
Segment by Type
  • Gelatin Capsules
  • Hypromellose Capsules
Segment by Application
  • Asthma
  • COPD (Chronic Obstructive Pulmonary Disease)
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Inbrija, Utibron Neohaler (Novartis AG), Zibo Laixu Medical Equipment
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Capsule-based Inhalers in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Capsule-based Inhalers manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Capsule-based Inhalers sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Capsule-based Inhalers Market report?

Ans: The main players in the Capsule-based Inhalers Market are Inbrija, Utibron Neohaler (Novartis AG), Zibo Laixu Medical Equipment

What are the Application segmentation covered in the Capsule-based Inhalers Market report?

Ans: The Applications covered in the Capsule-based Inhalers Market report are Asthma, COPD (Chronic Obstructive Pulmonary Disease)

What are the Type segmentation covered in the Capsule-based Inhalers Market report?

Ans: The Types covered in the Capsule-based Inhalers Market report are Gelatin Capsules, Hypromellose Capsules

1 Study Coverage
1.1 Capsule-based Inhalers Product Introduction
1.2 Market by Type
1.2.1 Global Capsule-based Inhalers Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Gelatin Capsules
1.2.3 Hypromellose Capsules
1.3 Market by Application
1.3.1 Global Capsule-based Inhalers Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Asthma
1.3.3 COPD (Chronic Obstructive Pulmonary Disease)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Capsule-based Inhalers Sales Estimates and Forecasts 2019-2030
2.2 Global Capsule-based Inhalers Revenue by Region
2.2.1 Global Capsule-based Inhalers Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Capsule-based Inhalers Revenue by Region (2019-2024)
2.2.3 Global Capsule-based Inhalers Revenue by Region (2025-2030)
2.2.4 Global Capsule-based Inhalers Revenue Market Share by Region (2019-2030)
2.3 Global Capsule-based Inhalers Sales Estimates and Forecasts 2019-2030
2.4 Global Capsule-based Inhalers Sales by Region
2.4.1 Global Capsule-based Inhalers Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Capsule-based Inhalers Sales by Region (2019-2024)
2.4.3 Global Capsule-based Inhalers Sales by Region (2025-2030)
2.4.4 Global Capsule-based Inhalers Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Capsule-based Inhalers Sales by Manufacturers
3.1.1 Global Capsule-based Inhalers Sales by Manufacturers (2019-2024)
3.1.2 Global Capsule-based Inhalers Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Capsule-based Inhalers in 2023
3.2 Global Capsule-based Inhalers Revenue by Manufacturers
3.2.1 Global Capsule-based Inhalers Revenue by Manufacturers (2019-2024)
3.2.2 Global Capsule-based Inhalers Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Capsule-based Inhalers Revenue in 2023
3.3 Global Key Players of Capsule-based Inhalers, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Capsule-based Inhalers Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Capsule-based Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Capsule-based Inhalers, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Capsule-based Inhalers, Product Offered and Application
3.8 Global Key Manufacturers of Capsule-based Inhalers, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Capsule-based Inhalers Sales by Type
4.1.1 Global Capsule-based Inhalers Historical Sales by Type (2019-2024)
4.1.2 Global Capsule-based Inhalers Forecasted Sales by Type (2025-2030)
4.1.3 Global Capsule-based Inhalers Sales Market Share by Type (2019-2030)
4.2 Global Capsule-based Inhalers Revenue by Type
4.2.1 Global Capsule-based Inhalers Historical Revenue by Type (2019-2024)
4.2.2 Global Capsule-based Inhalers Forecasted Revenue by Type (2025-2030)
4.2.3 Global Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
4.3 Global Capsule-based Inhalers Price by Type
4.3.1 Global Capsule-based Inhalers Price by Type (2019-2024)
4.3.2 Global Capsule-based Inhalers Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Capsule-based Inhalers Sales by Application
5.1.1 Global Capsule-based Inhalers Historical Sales by Application (2019-2024)
5.1.2 Global Capsule-based Inhalers Forecasted Sales by Application (2025-2030)
5.1.3 Global Capsule-based Inhalers Sales Market Share by Application (2019-2030)
5.2 Global Capsule-based Inhalers Revenue by Application
5.2.1 Global Capsule-based Inhalers Historical Revenue by Application (2019-2024)
5.2.2 Global Capsule-based Inhalers Forecasted Revenue by Application (2025-2030)
5.2.3 Global Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
5.3 Global Capsule-based Inhalers Price by Application
5.3.1 Global Capsule-based Inhalers Price by Application (2019-2024)
5.3.2 Global Capsule-based Inhalers Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Capsule-based Inhalers Market Size by Type
6.1.1 US & Canada Capsule-based Inhalers Sales by Type (2019-2030)
6.1.2 US & Canada Capsule-based Inhalers Revenue by Type (2019-2030)
6.2 US & Canada Capsule-based Inhalers Market Size by Application
6.2.1 US & Canada Capsule-based Inhalers Sales by Application (2019-2030)
6.2.2 US & Canada Capsule-based Inhalers Revenue by Application (2019-2030)
6.3 US & Canada Capsule-based Inhalers Market Size by Country
6.3.1 US & Canada Capsule-based Inhalers Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Capsule-based Inhalers Sales by Country (2019-2030)
6.3.3 US & Canada Capsule-based Inhalers Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Capsule-based Inhalers Market Size by Type
7.1.1 Europe Capsule-based Inhalers Sales by Type (2019-2030)
7.1.2 Europe Capsule-based Inhalers Revenue by Type (2019-2030)
7.2 Europe Capsule-based Inhalers Market Size by Application
7.2.1 Europe Capsule-based Inhalers Sales by Application (2019-2030)
7.2.2 Europe Capsule-based Inhalers Revenue by Application (2019-2030)
7.3 Europe Capsule-based Inhalers Market Size by Country
7.3.1 Europe Capsule-based Inhalers Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Capsule-based Inhalers Sales by Country (2019-2030)
7.3.3 Europe Capsule-based Inhalers Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Capsule-based Inhalers Market Size
8.1.1 China Capsule-based Inhalers Sales (2019-2030)
8.1.2 China Capsule-based Inhalers Revenue (2019-2030)
8.2 China Capsule-based Inhalers Market Size by Application
8.2.1 China Capsule-based Inhalers Sales by Application (2019-2030)
8.2.2 China Capsule-based Inhalers Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Capsule-based Inhalers Market Size by Type
9.1.1 Asia Capsule-based Inhalers Sales by Type (2019-2030)
9.1.2 Asia Capsule-based Inhalers Revenue by Type (2019-2030)
9.2 Asia Capsule-based Inhalers Market Size by Application
9.2.1 Asia Capsule-based Inhalers Sales by Application (2019-2030)
9.2.2 Asia Capsule-based Inhalers Revenue by Application (2019-2030)
9.3 Asia Capsule-based Inhalers Sales by Region
9.3.1 Asia Capsule-based Inhalers Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Capsule-based Inhalers Revenue by Region (2019-2030)
9.3.3 Asia Capsule-based Inhalers Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Capsule-based Inhalers Market Size by Type
10.1.1 Middle East, Africa and Latin America Capsule-based Inhalers Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Capsule-based Inhalers Market Size by Application
10.2.1 Middle East, Africa and Latin America Capsule-based Inhalers Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Capsule-based Inhalers Sales by Country
10.3.1 Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Capsule-based Inhalers Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Hovione
11.1.1 Hovione Company Information
11.1.2 Hovione Overview
11.1.3 Hovione Capsule-based Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Hovione Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hovione Recent Developments
11.2 Iconovo AB
11.2.1 Iconovo AB Company Information
11.2.2 Iconovo AB Overview
11.2.3 Iconovo AB Capsule-based Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Iconovo AB Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Iconovo AB Recent Developments
11.3 Inbrija
11.3.1 Inbrija Company Information
11.3.2 Inbrija Overview
11.3.3 Inbrija Capsule-based Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Inbrija Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Inbrija Recent Developments
11.4 Utibron Neohaler (Novartis AG)
11.4.1 Utibron Neohaler (Novartis AG) Company Information
11.4.2 Utibron Neohaler (Novartis AG) Overview
11.4.3 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Utibron Neohaler (Novartis AG) Recent Developments
11.5 Zibo Laixu Medical Equipment
11.5.1 Zibo Laixu Medical Equipment Company Information
11.5.2 Zibo Laixu Medical Equipment Overview
11.5.3 Zibo Laixu Medical Equipment Capsule-based Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Zibo Laixu Medical Equipment Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zibo Laixu Medical Equipment Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Capsule-based Inhalers Industry Chain Analysis
12.2 Capsule-based Inhalers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Capsule-based Inhalers Production Mode & Process
12.4 Capsule-based Inhalers Sales and Marketing
12.4.1 Capsule-based Inhalers Sales Channels
12.4.2 Capsule-based Inhalers Distributors
12.5 Capsule-based Inhalers Customers
13 Market Dynamics
13.1 Capsule-based Inhalers Industry Trends
13.2 Capsule-based Inhalers Market Drivers
13.3 Capsule-based Inhalers Market Challenges
13.4 Capsule-based Inhalers Market Restraints
14 Key Findings in The Global Capsule-based Inhalers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment
List of Tables
    Table 1. Global Capsule-based Inhalers Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Gelatin Capsules
    Table 3. Major Manufacturers of Hypromellose Capsules
    Table 4. Global Capsule-based Inhalers Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Capsule-based Inhalers Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Capsule-based Inhalers Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Capsule-based Inhalers Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Capsule-based Inhalers Revenue Market Share by Region (2019-2024)
    Table 9. Global Capsule-based Inhalers Revenue Market Share by Region (2025-2030)
    Table 10. Global Capsule-based Inhalers Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Capsule-based Inhalers Sales by Region (2019-2024) & (K Units)
    Table 12. Global Capsule-based Inhalers Sales by Region (2025-2030) & (K Units)
    Table 13. Global Capsule-based Inhalers Sales Market Share by Region (2019-2024)
    Table 14. Global Capsule-based Inhalers Sales Market Share by Region (2025-2030)
    Table 15. Global Capsule-based Inhalers Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Capsule-based Inhalers Sales Share by Manufacturers (2019-2024)
    Table 17. Global Capsule-based Inhalers Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Capsule-based Inhalers Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Capsule-based Inhalers, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Capsule-based Inhalers Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Capsule-based Inhalers Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Capsule-based Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Capsule-based Inhalers as of 2023)
    Table 23. Global Key Manufacturers of Capsule-based Inhalers, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Capsule-based Inhalers, Product Offered and Application
    Table 25. Global Key Manufacturers of Capsule-based Inhalers, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Capsule-based Inhalers Sales by Type (2019-2024) & (K Units)
    Table 28. Global Capsule-based Inhalers Sales by Type (2025-2030) & (K Units)
    Table 29. Global Capsule-based Inhalers Sales Share by Type (2019-2024)
    Table 30. Global Capsule-based Inhalers Sales Share by Type (2025-2030)
    Table 31. Global Capsule-based Inhalers Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Capsule-based Inhalers Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Capsule-based Inhalers Revenue Share by Type (2019-2024)
    Table 34. Global Capsule-based Inhalers Revenue Share by Type (2025-2030)
    Table 35. Capsule-based Inhalers Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Capsule-based Inhalers Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Capsule-based Inhalers Sales by Application (2019-2024) & (K Units)
    Table 38. Global Capsule-based Inhalers Sales by Application (2025-2030) & (K Units)
    Table 39. Global Capsule-based Inhalers Sales Share by Application (2019-2024)
    Table 40. Global Capsule-based Inhalers Sales Share by Application (2025-2030)
    Table 41. Global Capsule-based Inhalers Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Capsule-based Inhalers Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Capsule-based Inhalers Revenue Share by Application (2019-2024)
    Table 44. Global Capsule-based Inhalers Revenue Share by Application (2025-2030)
    Table 45. Capsule-based Inhalers Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Capsule-based Inhalers Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Capsule-based Inhalers Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Capsule-based Inhalers Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Capsule-based Inhalers Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Capsule-based Inhalers Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Capsule-based Inhalers Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Capsule-based Inhalers Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Capsule-based Inhalers Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Capsule-based Inhalers Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Capsule-based Inhalers Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Capsule-based Inhalers Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Capsule-based Inhalers Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Capsule-based Inhalers Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Capsule-based Inhalers Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Capsule-based Inhalers Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Capsule-based Inhalers Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Capsule-based Inhalers Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Capsule-based Inhalers Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Capsule-based Inhalers Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Capsule-based Inhalers Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Capsule-based Inhalers Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Capsule-based Inhalers Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Capsule-based Inhalers Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Capsule-based Inhalers Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Capsule-based Inhalers Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Capsule-based Inhalers Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Capsule-based Inhalers Sales by Country (2025-2030) & (K Units)
    Table 73. China Capsule-based Inhalers Sales by Type (2019-2024) & (K Units)
    Table 74. China Capsule-based Inhalers Sales by Type (2025-2030) & (K Units)
    Table 75. China Capsule-based Inhalers Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Capsule-based Inhalers Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Capsule-based Inhalers Sales by Application (2019-2024) & (K Units)
    Table 78. China Capsule-based Inhalers Sales by Application (2025-2030) & (K Units)
    Table 79. China Capsule-based Inhalers Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Capsule-based Inhalers Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Capsule-based Inhalers Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Capsule-based Inhalers Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Capsule-based Inhalers Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Capsule-based Inhalers Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Capsule-based Inhalers Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Capsule-based Inhalers Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Capsule-based Inhalers Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Capsule-based Inhalers Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Capsule-based Inhalers Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Capsule-based Inhalers Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Capsule-based Inhalers Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Capsule-based Inhalers Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Capsule-based Inhalers Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Capsule-based Inhalers Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Capsule-based Inhalers Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Capsule-based Inhalers Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Capsule-based Inhalers Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Capsule-based Inhalers Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Capsule-based Inhalers Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Capsule-based Inhalers Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Capsule-based Inhalers Sales by Country (2025-2030) & (K Units)
    Table 107. Hovione Company Information
    Table 108. Hovione Description and Major Businesses
    Table 109. Hovione Capsule-based Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Hovione Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Hovione Recent Developments
    Table 112. Iconovo AB Company Information
    Table 113. Iconovo AB Description and Major Businesses
    Table 114. Iconovo AB Capsule-based Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Iconovo AB Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Iconovo AB Recent Developments
    Table 117. Inbrija Company Information
    Table 118. Inbrija Description and Major Businesses
    Table 119. Inbrija Capsule-based Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Inbrija Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Inbrija Recent Developments
    Table 122. Utibron Neohaler (Novartis AG) Company Information
    Table 123. Utibron Neohaler (Novartis AG) Description and Major Businesses
    Table 124. Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Utibron Neohaler (Novartis AG) Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Utibron Neohaler (Novartis AG) Recent Developments
    Table 127. Zibo Laixu Medical Equipment Company Information
    Table 128. Zibo Laixu Medical Equipment Description and Major Businesses
    Table 129. Zibo Laixu Medical Equipment Capsule-based Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Zibo Laixu Medical Equipment Capsule-based Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Zibo Laixu Medical Equipment Recent Developments
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Capsule-based Inhalers Distributors List
    Table 135. Capsule-based Inhalers Customers List
    Table 136. Capsule-based Inhalers Market Trends
    Table 137. Capsule-based Inhalers Market Drivers
    Table 138. Capsule-based Inhalers Market Challenges
    Table 139. Capsule-based Inhalers Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Capsule-based Inhalers Product Picture
    Figure 2. Global Capsule-based Inhalers Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Capsule-based Inhalers Market Share by Type in 2023 & 2030
    Figure 4. Gelatin Capsules Product Picture
    Figure 5. Hypromellose Capsules Product Picture
    Figure 6. Global Capsule-based Inhalers Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Capsule-based Inhalers Market Share by Application in 2023 & 2030
    Figure 8. Asthma
    Figure 9. COPD (Chronic Obstructive Pulmonary Disease)
    Figure 10. Capsule-based Inhalers Report Years Considered
    Figure 11. Global Capsule-based Inhalers Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Capsule-based Inhalers Revenue 2019-2030 (US$ Million)
    Figure 13. Global Capsule-based Inhalers Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Capsule-based Inhalers Revenue Market Share by Region (2019-2030)
    Figure 15. Global Capsule-based Inhalers Sales 2019-2030 ((K Units)
    Figure 16. Global Capsule-based Inhalers Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Capsule-based Inhalers Sales YoY (2019-2030) & (K Units)
    Figure 18. US & Canada Capsule-based Inhalers Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Capsule-based Inhalers Sales YoY (2019-2030) & (K Units)
    Figure 20. Europe Capsule-based Inhalers Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Capsule-based Inhalers Sales YoY (2019-2030) & (K Units)
    Figure 22. China Capsule-based Inhalers Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Capsule-based Inhalers Sales YoY (2019-2030) & (K Units)
    Figure 24. Asia (excluding China) Capsule-based Inhalers Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Capsule-based Inhalers Sales YoY (2019-2030) & (K Units)
    Figure 26. Middle East, Africa and Latin America Capsule-based Inhalers Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Capsule-based Inhalers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Capsule-based Inhalers in the World: Market Share by Capsule-based Inhalers Revenue in 2023
    Figure 29. Global Capsule-based Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Capsule-based Inhalers Sales Market Share by Type (2019-2030)
    Figure 31. Global Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
    Figure 32. Global Capsule-based Inhalers Sales Market Share by Application (2019-2030)
    Figure 33. Global Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Capsule-based Inhalers Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Capsule-based Inhalers Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Capsule-based Inhalers Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Capsule-based Inhalers Sales Share by Country (2019-2030)
    Figure 40. U.S. Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Capsule-based Inhalers Sales Market Share by Type (2019-2030)
    Figure 43. Europe Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Capsule-based Inhalers Sales Market Share by Application (2019-2030)
    Figure 45. Europe Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Capsule-based Inhalers Revenue Share by Country (2019-2030)
    Figure 47. Europe Capsule-based Inhalers Sales Share by Country (2019-2030)
    Figure 48. Germany Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 49. France Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 53. China Capsule-based Inhalers Sales Market Share by Type (2019-2030)
    Figure 54. China Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
    Figure 55. China Capsule-based Inhalers Sales Market Share by Application (2019-2030)
    Figure 56. China Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Capsule-based Inhalers Sales Market Share by Type (2019-2030)
    Figure 58. Asia Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Capsule-based Inhalers Sales Market Share by Application (2019-2030)
    Figure 60. Asia Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Capsule-based Inhalers Revenue Share by Region (2019-2030)
    Figure 62. Asia Capsule-based Inhalers Sales Share by Region (2019-2030)
    Figure 63. Japan Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 67. India Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Capsule-based Inhalers Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Capsule-based Inhalers Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Capsule-based Inhalers Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Capsule-based Inhalers Sales Share by Country (2019-2030)
    Figure 74. Brazil Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Capsule-based Inhalers Revenue (2019-2030) & (US$ Million)
    Figure 79. Capsule-based Inhalers Value Chain
    Figure 80. Capsule-based Inhalers Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Respiratory Care Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-39Z339
Wed Mar 19 00:00:00 UTC 2025

$8500

Enterprise User

Add to Cart

Global Inhalers and Nebulizers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10M11487
Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eosinophilic Asthma Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8G6224
Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Inhalation Preparation Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24C12273
Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions